Natural antisense transcripts (NATs) exist ubiquitously in mammalian genomes and play roles in the regulation of gene expression. However, both the existence of bidirectional antisense RNA regulation and the possibility of proteincoding genes that function as antisense RNAs remain speculative. Here, we found that the protein-coding gene, deoxyhypusine synthase (DHPS), as the NAT of WDR83, concordantly regulated the expression of WDR83 mRNA and protein. Conversely, WDR83 also regulated DHPS by antisense pairing in a concordant manner. WDR83 and DHPS were capable of forming an RNA duplex at overlapping 3′ untranslated regions and this duplex increased their mutual stability, which was required for the bidirectional regulation. As a pair of protein-coding cis-sense/antisense transcripts, WDR83 and DHPS were upregulated simultaneously and correlated positively in gastric cancer (GC), driving GC pathophysiology by promoting cell proliferation. Furthermore, the positive relationship between WDR83 and DHPS was also observed in other cancers. The bidirectional regulatory relationship between WDR83 and DHPS not only enriches our understanding of antisense regulation, but also provides a more complete understanding of their functions in tumor development.
Introduction
Natural antisense transcripts (NATs) are defined as RNA molecules that are complementary to their endogenous sense genes [1, 2] . They are generally classified into two types: cis-NATs that are transcribed from the opposite strands of their sense genes [3] and trans-NATs that are transcribed at different genomic loci from their sense partners [4] . With advances in delineating the transcriptome, a number of NATs have been systematically identified in mammalian genomes; for example, up to 72% of transcripts have been demonstrated to have antisense partners in mammalian transcriptomes [1, 5, 6] . NATs play important roles in many physiological and pathological processes, including genomic imprinting, alternative splicing, X inactivation, mRNA stability, and translational regulation [6, 7] . Many reports have demonstrated that antisense transcripts can regulate the expression of sense genes. However, few reports have investigated whether bidirectional regulation can exist between antisense RNAs and sense protein-coding genes. In addition, recent efforts have paid close attention to noncoding RNAs (ncRNAs) as antisense transcripts of sense genes [8, 9] . To date, no systematic studies have been published, which discuss antisense protein-coding genes that can affect sense protein-coding genes. Considering the widespread amount of antisense transcription and the pivotal role of antisense RNA regulation, this field is of great interest.
WDR83 (also known as MORG1) functions as a module in the assembly of a multi-component scaffold for components of the ERK-MAPK pathway, including ERK1/2, MEK1/2, Raf-1, and B-Raf; it also selectively facilitates ERK1/2 activation in response to a subset of agonists [10, 11] . The aberrant activation of the ERK signaling, which contributes to tumorigenesis by promoting cell proliferation [12, 13] , has been frequently observed in cancers. WDR83 also interacts with eglnine homolog 3 (EGLN3, also known as PHD3 (prolyl-hydroxylase 3)) and regulates the expression of hypoxia-inducible factor 1 (HIF-1) [14] . As the major regulator of the hypoxic adaptive response, HIF-1 plays key roles in tumorigenesis [15] . Considering the essential role of WDR83 in ERK signaling and tumorigenesis, the regulation of WDR83 at either the protein or RNA level may influence its associated pathways and the overall process of tumorigenesis.
In this study, we described a cis-sense/antisense (cis-SA) pair that consisted of two protein-coding genes, WDR83 and deoxyhypusine synthase (DHPS). This cis-SA pair was originally identified by the Natural Antisense Transcript Database (NATsDB) [16] . We showed that DHPS, as the cis-NAT for WDR83, was increased in parallel with WDR83 in gastric cancer (GC). DHPS could increase the mRNA and protein expression of WDR83 through their overlapping 3′ untranslated regions (3′UTRs). WDR83 also regulated DHPS expression in a concordant manner. The underlying mechanisms and consequences of this regulatory process were further investigated.
Results

WDR83 and DHPS were upregulated simultaneously and positively correlated in GC
From NATsDB, a database that is based on millions of human ESTs and mRNAs, we identified that DHPS and WDR83 are transcribed from opposite strands of the same region of chromosome 19. Both WDR83 and DHPS had three splice variants, and they formed a 'tail-to-tail' pairing pattern, including 113 nucleotides with full complementarity to their constitutive 3′UTRs (Figure 1 ).
WDR83 and DHPS may be subjected to complicated antisense regulation. To investigate this hypothesis, their expression was examined by quantitative real-time PCR (qPCR) analyses between 19 pairs of human GC tissues and matched normal tissues. Both WDR83 and DHPS mRNA expressions were significantly increased in GC samples compared with their nontumorous counterparts (P = 0.0198 and P = 0.0286, respectively; Figure 2A ). We found that the protein expression levels of WDR83 and DHPS were also elevated in primary GC tissues using immunohistochemistry (IHC; Figure 2B and 2C). These observations suggested that the expression of WDR83 and DHPS at both the mRNA and protein levels may be regulated concordantly. Interestingly, linear regression analysis revealed a strong positive correlation between DHPS and WDR83 mRNA expression in GC (r = 0.7107, P < 0.0001, Figure 2D ). Furthermore, transcription expression profiling in another 504 normal tissues using the Affymetrix U133 Plus2.0 array also confirmed the significantly positive correlation between WDR83 and DHPS (P < 0.001, Figure 2E-2G) . The positive correlation coefficient was small but strongly significant, indicating that the concordant regulation between WDR83 and DHPS expression was of importance. Finally, subcellular location profiling of four different cell lines using the Affymetrix Tiling Array revealed that WDR83 and DHPS transcripts were widely expressed in both the cytoplasm and nucleus ( Figure 2H ), suggesting that these two genes were expressed in the same subcellular locations, which may be convenient for antisense regulation to occur. However, the exact underlying molecular mechanisms remain unclear.
DHPS mRNA regulated WDR83 through antisense overlapping
The common function of antisense transcripts is to regulate the expression of sense transcripts [1] . To investigate whether DHPS could modulate the expression of WDR83, specific siRNAs that target the non-overlapping regions of DHPS were transfected into the MGC803 GC cell line. The results showed that knockdown of DHPS by siRNA led to a significant decrease not only in the level of the targeted DHPS mRNA but also in the level of WDR83 mRNA ( Figure 3A) . Western blotting analysis displayed that siRNAs targeting against DHPS also reduced the expression of WDR83 protein ( Figure  3B ). Thus, the data suggested that DHPS could regulate WDR83 at both mRNA and protein expression levels.
We further examined whether DHPS mRNA or protein perform the regulation of WDR83. We constructed three different plasmids: (1) pIRES2-DHPS-full length, containing the full-length DHPS transcript; (2) pIRES2-DHPS-CDS, containing the coding region of the DHPS transcript; and (3) pIRES2-DHPS-3′UTR containing only the 3′UTR of the DHPS transcript (described in Materials and Methods). These plasmids were transfected into MGC803 cells separately. Compared with the control vector, the overexpression of plasmids that contained the DHPS 3′UTR (pIRES2-DHPS-full length or pIRES2-DHPS-3′UTR) resulted in a significant increase in WDR83 mRNA and protein levels, whereas plasmids that lacked overlapping 3′UTR regions (pIRES2-DHPS-CDS) did not have an obvious effect on WDR83 expression ( Figure 3C and 3D ). These data indicated that DHPS mRNA, rather than DHPS protein, regulated WDR83, and that the antisense 3′UTR of DHPS might play an important role in this regulation. Furthermore, the transfection of DHPS 3′UTR plasmids (pIRES2-DHPS-3′UTR) into MGC803 cells rescued the downregulation of WDR83 after DHPS knockdown (P = 0.0145, Figure  3E ). Thus, the 3′UTR of DHPS was essential for the regulation of WDR83 mRNA expression.
To further test whether the DHPS 3′UTR regulated WDR83 expression through antisense pairing, we generated a luciferase reporter construct (pmirGLO-WDR83-3′UTR) that carried the WDR83 3′UTR. A 113-bp fragment of the WDR83 3′UTR, which covered the entire overlapping region, was inserted downstream of the luciferase reporter gene in the pmirGLO vector. We examined the effects of DHPS overexpression or knockdown on pmirGLO-WDR83-3′UTR activity. Strikingly, the luciferase activity of pmirGLO-WDR83-3′UTR significantly increased in cells that were cotransfected with the DHPS-3′UTR plasmid (P = 0.0020, Figure 3F ), and the overexpression of the DHPS full-length construct also induced an increase in luciferase activity (P = 0.0310, Figure 3F ). The DHPS CDS-containing construct did not have an obvious effect on pmirGLO-WDR83-3′UTR (P = 0.7845, Figure 3F ). Meanwhile, silencing DHPS decreased the luciferase activity of pmirGLO-WDR83-3′UTR (P = 0.0158, Figure 3F ). These results were consistent with our observation that the overexpression of the DHPS 3′UTR resulted in a significant increase in WDR83 mRNA and protein levels. Taken together, our WDR83 and DHPS expression were significantly increased in GC tissues compared with their normal tissues (P = 0.0198 and 0.0286, respectively, n = 19; *P < 0.05, **P < 0.01, ANOVA). (B, C) Representative expression of WDR83 and DHPS in GC specimens and their matched normal tissues as determined by IHC (magnification 200×); in GC tissues, high-level expression of WDR83 or DHPS was shown by strong staining. (D) Regression analysis of WDR83 and DHPS expression revealed that WDR83 and DHPS were positively correlated (r = 0.7107, P < 0.0001). The correlation coefficient (r) measured the reliability and the P-value measured the statistical significance of the correlation between the x and y variables. (E-G) Expression correlation analysis of WDR83 and DHPS in 504 normal tissues: (E) the expression of WDR83 (probe 224434_ s_at, blue) and DHPS (probe 202802_at, red) exhibited a significantly positive correlation (r = 0.167, P < 0.00016); (F) the expression of WDR83 (probe 224434_s_at, blue) and DHPS (probe 207831_at, orange) also exhibited a significantly positive correlation (r = 0.171, P < 0.00012); (G) the expression of WDR83 (probe 224434_s_at, blue) and DHPS (probe 211558_s_ at, green) exhibited concordant expression patterns (r = 0.140, P < 0.00017). (H) Subcellular location profiling of WDR83 and DHPS using the Affymetrix Tiling Array revealed that both genes were widely expressed in the cytoplasm and nucleus in different cell lines.
www.cell-research.com | Cell Research Wen-Yu Su et al. 1377 npg data demonstrated that the DHPS overlapping 3′UTR mediated the regulation of WDR83 expression through antisense pairing, which supported the notion that although the 3′UTR had no coding potential, it exerted a biological effect [17] . The luciferase reporter assay showed that the WDR83 3′UTR-containing construct induced a 24.4% increase in luciferase activity in cells that were cotransfected with the DHPS 3′UTR plasmid (P = 0.0020), and the WDR83 full-length construct also showed an increase in luciferase activity (P = 0.0310). The DHPS CDS-containing construct did not have an obvious effect on pmirGLO-WDR83-3′UTR (P = 0.7845). Meanwhile, silencing DHPS decreased luciferase activity (P = 0.0158). Relative firefly luciferase activity over renilla luciferase activity: FL/RL, n ≥ 3, ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001.
npg WDR83 mRNA also regulated DHPS through antisense pairing To study whether there was a possible regulation of DHPS by WDR83, DHPS mRNA and protein expression were examined by silencing WDR83. Unexpectedly, we observed that the knockdown of WDR83 resulted in significant reductions of DHPS mRNA and protein expression levels ( Figure 4A and 4B). To further examine this regulatory process, we constructed three different plasmids (described in Materials and Methods) and transfected them separately into MGC803 cells. Interestingly, the data showed that the pIRES2-WDR83-3′UTR and pIRES2-WDR83-full length plasmids dramatically increased levels of DHPS mRNA and protein, whereas the pIRES2-WDR83-CDS plasmid did not affect the expression of DHPS significantly ( Figure 4C and 4D). These observations indicated that WDR83 mRNA, rather than the WDR83 protein, performed the regulation. Furthermore, the transfection of WDR83 3′UTR plasmids (pIRES2-WDR83-3′UTR) rescued the downregulation of DHPS after the WDR83 knockdown (P = 0.0233, Figure  4E ). Simultaneously, we observed that the luciferase activity of pmirGLO-DHPS-3′UTR was significantly increased in cells that were cotransfected with either the WDR83 3′UTR plasmid or the WDR83 full-length plasmid (P = 0.0481 and 0.0490, respectively, Figure 4F ). The luciferase activity of pmirGLO-DHPS-3′UTR was markedly decreased in cells with the WDR83 knockdown (P = 0.0059, Figure 4F ). Our observations further confirmed that the regulation of DHPS mRNA and protein expression by WDR83 was dependent on 3′UTR antisense pairing. Collectively, there was a bidirectional regulation between WDR83 and DHPS, which was consistent with our observations that the expression levels of WDR83 and DHPS were positively correlated in GC.
DHPS and WDR83 formed an RNA duplex and mutually increased their stability
The above data revealed that the overlapping 3′UTR was critical in a bidirectional regulation between WDR83 and DHPS. Sense and antisense transcripts may potentially form double-stranded RNA structures that regulate the stability, transport or translation of the sense transcript [7] . To examine the possibility of RNA duplex formation between WDR83 and DHPS, we cotransfected the WDR83 3′UTR plasmids and DHPS 3′UTR plasmids into MGC803 cells, and performed an RNase protection assay on RNA from MGC803 cells. Single-stranded RNA was digested with RNase A and the remaining double-stranded RNA was analyzed by RT-PCR using primers that corresponded to different regions of both transcripts. Only primers within the overlapping region of WDR83 and DHPS generated a PCR product ( Figure  5A ). Therefore, the overlapping part of both transcripts was protected from degradation. It was therefore expected that blocking the RNA/RNA interaction could inhibit the bidirectional regulation between these two genes. We designed 2′-O-methyl oligoribonucleotides to inhibit the formation of the WDR83/DHPS RNA duplex. These oligoribonucleotides were small single-stranded RNA fragments that were utilized previously to block SA pairing [18] and miRNA binding to miRNA targets [19] . As shown in Figure 5B , the transfection of DHPS-specific oligonucleotides resulted in a decrease of WDR83 transcripts (P = 0.0192); meanwhile, the transfection of WDR83-specific oligonucleotides reduced DHPS transcripts (P < 0.001). These data further confirmed that the RNA-RNA duplex was required for the bidirectional regulation between WDR83 and DHPS.
It was reported that the RNA-RNA duplex could protect mRNA from RNase degradation and enhance mRNA stability [9, 20] . To investigate whether the overlapping 3′UTR of WDR83 and DHPS RNA duplex affected the stability of the mRNA, we blocked any new mRNA synthesis with α-amanitin (an RNA polymerase II inhibitor) and analyzed the expression of WDR83, DHPS, GAPDH and 18S RNA over a 24-h period. 18S RNA, which was a product of RNA polymerase I and was unchanged after α-amanitin treatment, served as the internal control [9] . As shown in Figure 5C , compared with control siRNAs, treatment with the specific siRNAs against DHPS resulted in a decreased stability of WDR83 mRNA; WDR83 knockdown also caused a reduced stability of DHPS mRNA. Taken together, these results suggested that the RNA duplex formed between WDR83 and DHPS increased the stability of both transcripts, which was required for their bidirectional regulation.
The above data proved that bidirectional antisense regulation occurred, at least at the post-transcriptional level. To examine whether this regulation might occur at the transcriptional level, we designed specific primers (listed in Supplementary information, Table S1 ) to detect the expression of DHPS or WDR83 pre-mRNA. Neither the expression of WDR83 pre-mRNA nor the expression of DHPS pre-mRNA was significantly changed when the partner gene was overexpressed or silenced (Supplementary information, Figure S1 ), which indicated that transcriptional regulation might not participate in the DHPS-WDR83 antisense control.
DHPS and WDR83 participated in the regulation of ERK signaling and E2F1 in GC cells
It has been reported that WDR83 selectively facilitates the activation of ERK signaling in an agonist-specific 
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Western blot analysis indicated that WDR83 downregulation also caused a decrease in DHPS protein expression. (C) Quantification of DHPS mRNA levels after overexpression of three different plasmids in MGC803 cells. qPCR analysis revealed that overexpression of only the transcripts containing the overlapping regions (WDR83-full length or WDR83-3′UTR) resulted in a significant increase in DHPS mRNA levels (n ≥ 3, P = 0.0014 and 0.0165, respectively). (D) Western blot analysis demonstrated that WDR83-full length or WDR83-3′UTR significantly increased DHPS protein levels in MGC803 cells. (E) Endogenous WDR83 was first knocked down by siRNA for 24 h and then restored by the exogenous expression of WDR83-3′UTR (pIRES2-WDR83-3′UTR) for further 24 h. Cells were harvested and the levels of DHPS mRNA were measured by qPCR. (F) The luciferase activity of pmirGLO-DHPS-3′UTR was increased significantly in cells that were cotransfected with the WDR83 3′UTR plasmid or the WDR83 full-length plasmid (P = 0.0481 and 0.0490, respectively), and the luciferase activity of pmirGLO-DHPS-3′UTR was markedly decreased in cells with knocked down WDR83 (P = 0.006; n ≥ 3, ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001).
www.cell-research.com | Cell Research . MGC803 cells were transfected with siRNA against WDR83 or DHPS or control siRNA for 24 h, and were then further exposed to 25 mM α-amanitin for 6, 12 and 24 h. Cells were harvested and the stability of the WDR83 and DHPS mRNA was analyzed by qPCR. 18S RNA, which was a product of RNA polymerase I and was unchanged after α-amanitin treatment, was used as the control.
manner [10] . The aberrant activation of the ERK pathway is frequently observed in human cancers [21, 22] . To test whether WDR83 participated in agonist-specific ERK signaling in GC, MGC803 cells were transfected with WDR83 siRNAs. After serum starvation, cells were stimulated with 5 nM phorbol 12-myristate 13-acetate (PMA) and ERK activation was assessed by western blotting using an anti-phospho-ERK antibody. As shown in Figure 6A , the WDR83 knockdown dramatically decreased the PMA-stimulated phosphorylation of ERK1/2 in MGC803 cells; however, no detectable changes in total ERK1/2 protein were seen in WDR83 siRNAs-treated lysates. Thus, these findings suggested that WDR83 could facilitate agonist-specific ERK activation in GC and were consistent with results previously reported in HeLa cells [10] . We also observed that the DHPS knockdown decreased ERK1/2 phosphorylation in response to PMA ( Figure 6A ). In contrast, the overexpression of either WDR83 or DHPS in combination with PMA enhanced ERK1/2 phosphorylation ( Figure 6B ). Taken together, these data suggested that both WDR83 and DHPS enhanced the activation of ERK signaling. Activated ERK1/2 might lead to the release and activation of the transcriptional factor, E2F1 [23, 24] . Indeed, silencing ERK1/2 in MGC803 cells led to reduced E2F1 protein levels compared to control siRNAs ( Figure  6C ), suggesting that ERK1/2 could mediate E2F1 activation in GC, which was consistent with previous reports in HECs cells [25] . Considering that WDR83 and DHPS could facilitate ERK signaling activation, we further examined whether E2F1 could be modulated by WDR83 or DHPS in GC cells. As shown in Figure 6C , the knockdown of either WDR83 or DHPS resulted in a decrease in E2F1 protein expression compared with control siRNAs, and the overexpression of either WDR83 or DHPS induced an increase in E2F1 protein levels ( Figure 6D ).
Both WDR83 and DHPS enhanced cell proliferation
Our finding that WDR83 and DHPS expression was significantly increased in GC samples prompted us to explore their functional significance in GC. As illustrated in Figure 6E , the downregulation of WDR83 or DHPS inhibited the cell proliferation in GC cells. In contrast, the overexpression of either WDR83 or DHPS enhanced cell proliferation ( Figure 6F and 6G) . The joint overexpression of WDR83 and DHPS enhanced cell proliferation even further ( Figure 6H ). Therefore, WDR83 and DHPS might be involved in the control of cell proliferation in GC cells.
The interaction between WDR83 and DHPS existed in other cancers and species
To extend our studies beyond GC, we examined the expression of WDR83 and DHPS in other cancer types. Transcriptional profiling of normal and cancer cell lines from the University of Washington Encyclopedia of DNA Elements (ENCODE) group (downloaded from the University of California, Santa Cruz (UCSC) database [26] ) was performed. Compared with normal cell lines, the expressions of WDR83 and DHPS in cancer cell lines (described in Supplementary information, Data S1) were markedly increased (P = 0.0033 and 0.03, respectively, Figure 7A ) and positively correlated (r = 0.7047, P = 0.0016, Figure 7B ). These results provided evidence that WDR83 and DHPS play important roles in tumor progression and the positive correlation between them was common to other cancers. Moreover, a significant increase in E2F1 expression was observed in cancer cells compared with normal cells (P = 0.0029, Figure 7A ), which indicated the essential role of E2F1 in cancer biogenesis. Meanwhile, the expression of E2F1 and DHPS, as well as E2F1 and WDR83, exhibited significantly positive correlations in multiple cell lines (r = 0.6262, P = 0.007159, Figure 7C and r = 0.8237, P = 0.0004833, Figure 7D ). This finding supported our observations that WDR83 and DHPS might contribute to the enhancement of cell proliferation in GC cells.
Next, we studied the evolution of the interaction between WDR83 and DHPS in other species. Based on the HomoloGene annotation [27] , WDR83 and DHPS were found to be well conserved at the protein level. They were widely expressed in eukaryotes (HomoloGene 12194 and 1453, respectively). The ensemble 64 gene tree homology annotation confirmed that both genes had one-to-one orthologs in most eukaryotes, with the exception of at least two DHPS paralogs in stickleback and puffer fish. As we showed that DHPS and WDR83 exhibited bidirectional RNA-RNA interaction through their overlapping 3′UTRs, we were interested in investigating whether their overlapping regions were as well conserved as their protein products. By tracking their genomic regions in well-annotated genomes, we found that DHPS and WDR83 were not located at the same locus until the origin of tetrapoda. Furthermore, in order to track when these two genes formed a cis-sense/antisense pair, we selected representative species from distinct phylogenetic branches of tetrapoda. The DHPS and WDR83 genes in these species contained identical 3′ end structures based on the transcriptome data (Supplementary information, Table S2 and Figure S2 ). These results showed that they overlapped with each other in all species, suggesting that they had formed cis-sense/antisense pairs since the origin of tetrapoda. and DHPS enhanced cell proliferation even further (P = 0.0037). Cell proliferation was determined by the CCK-8 assay (n ≥ 3, ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001). were well conserved in the coding region across eukaryotes, the cis-RNA-RNA interactions between WDR83 and DHPS only existed in tetrapoda and were relatively young in terms of evolution compared to the coding region.
Discussion
In this study, we characterized a cis-SA pair that consisted of two protein-coding genes, WDR83 and DHPS, which were upregulated simultaneously and positively correlated in GC and other cancers. The regulation between DHPS and WDR83 was bidirectional. They mutually affected both of their mRNA and protein expression levels through their overlapping 3′UTRs. Different from previous unidirectional cis-SA regulation [18] , the bidirectional regulation between WDR83 and DHPS enriches the understanding of post-transcriptional antisense regulation, as it indicates that SA interactions are much more complicated than previously thought.
There were two types of regulation between sense and NATs: (1) discordant regulation, where the NATs inhibit the sense RNAs or proteins; and (2) concordant regulation, where NATs increase the level of the sense RNAs or the corresponding proteins [9, 28] . Here, the regulation between WDR83 and DHPS occurred in a concordant manner. This could at least be explained that the cis-SA pairing was capable of forming a sense-antisense RNA duplex at their overlapping regions, which might reduce mRNA degradation at the post-transcriptional level. Although endogenous RNA duplexes have been difficult to identify in human cells [18, 29] , blocking the WDR83/DHPS RNA-RNA interaction with 2′-O-methyl oligoribonucleotides and in vitro RNA-duplex detection provided solid evidence that these two genes could form an RNA duplex. Other possible mechanisms for their concordant expression require further investigation.
The overexpression of DHPS 3′UTR or DHPS fulllength construct significantly increased WDR83 expression and the luciferase activity of pmirGLO-DHPS-
npg 3′UTR. The same result was obtained in the regulation of DHPS by WDR83. However, the change of gene expression level or the luciferase activity in cells that were transfected with the partner gene full-length plasmids was lower than those achieved with 3′UTR plasmids. This difference was possibly due to the secondary structure formed by the full-length sequence. The intramolecular secondary structure might constrain the accessibility of nucleotides, which participated in inter-molecular interactions [30] . This might interfere with intermolecular antisense regulation. Using Mfold [31] , we predicted the secondary structures of DHPS and WDR83 full-length sequences and indeed found that the antisense overlapping regions participated in secondary structure formation with other regions (Supplementary information, Figure S3 ). Nevertheless, the results still supported the conclusion that the antisense 3′UTR played essential roles in bidirectional RNA regulation. The overlapping region of WDR83 and DHPS was shown to exist since tetrapoda. The conservation of genomic elements suggested functional importance. We investigated the expression pattern of murine Wdr83 and Dhps in four mouse tissue types following acute caloric restriction [32] , and found a strongly positive correlation between Dhps and Wdr83 mRNA expression (Supplementary information, Figure S4 ), which was similar to the pattern observed in human cancers. The expression pattern indicated that Dhps and Wdr83 might also perform a concordant antisense regulatory function in the mouse. Although the overlapping regions and coding regions of WDR83 and DHPS were highly conserved across species, the neighboring regions of these two genes differed between the human and mouse genomes. In humans, WDR83 shares a putative bidirectional promoter with another gene, MAN2B1. In the mouse, Wdr83 shares a putative bidirectional promoter with the BC056474 gene, which is not homologous to the human MAN2B1, indicating a different gene chain between species [33, 34] . As a bidirectional promoter might lead to the coexpression of neighboring genes [35] , the interspecies gene structure differences within this genomic locus might result in the coexpression of distinct gene triplets.
The bidirectional regulation between WDR83 and DHPS might at least be due to the WDR83-DHPS RNA duplex that forms at their overlapping 3′UTRs, where the deadenylation-dependent mRNA decay pathway is initiated and the poly(A)-tail is shortened [36] . The RNA duplex might protect their 3′ ends from being attacked by exosomes. Another mechanism for the bidirectional regulation might be associated with RNA duplex masking miRNA-binding sites in both genes. It has been reported that antisense transcripts might compete for binding sites against miRNAs and obstruct miRNA-mediated regulation of target genes [37] . Indeed, based on the microcosm database [38] , we found 27 miRNA target sites in WDR83 and 11 miRNA-binding sites in DHPS at their overlapping regions (Supplementary information, Tables  S3 and S4) . Therefore, antisense pairing between WDR83 and DHPS might also interrupt the miRNA-mediated inhibition of target genes, which would increase the mRNA stability or the translation efficiency of both transcripts. However, further study on the exact mechanism is necessary.
In addition, we demonstrated that DHPS and WDR83 mRNA displayed two functions: they delivered proteincoding information by protein synthesis and exerted endogenous post-transcriptional regulatory roles in their mutual expression through their overlapping 3′UTRs. The canonical role of mRNA is to deliver protein-coding information to sites of protein synthesis, but our findings have shown that mRNAs also exert regulatory roles in their targeting genes, independently of their protein-coding functions. Thus, our observations emphasize the need to move beyond the confines of protein-coding mRNA and to highlight the regulatory roles of mRNA.
We also evaluated the biological function of WDR83 and DHPS in GC. WDR83 and DHPS played important roles in driving GC pathophysiology. The downregulation of WDR83 or DHPS inhibited cell proliferation in GC cells; conversely, the overexpression of WDR83 or DHPS enhanced cell proliferation. Therefore, WDR83 and DHPS drove GC pathophysiology by promoting cell proliferation. It has been reported that aberrant activation of ERK signaling was frequently seen in human cancers and clearly contributed to enhancing cell proliferation and survival [21, 22] . E2F1 was also an important component of cell proliferation control [39, 40] . Thus, the enhanced cell proliferation in GC cells by WDR83 and DHPS was perhaps possible as both genes were involved in the regulation of ERK signaling activation and E2F1 expression. Moreover, we extended our studies to other cancers. An analysis of transcriptional profiles from EN-CODE group indicated that the expression of WDR83 and DHPS was also markedly increased in other cancers, which supported our hypothesis that both DHPS and WDR83 have oncogenic roles.
In this study, we studied the influence of antisense regulation on ERK signaling. WDR83 also attenuated expression of the HIF-1α by activating or stabilizing PHD3 [14, 41] . This antisense interaction might also indirectly regulate HIF-1α. More interestingly, HIF-1α was reported to be regulated by its two NATs [42, 43] . Therefore, the regulation of HIF-1α may be more complex than previously thought, as it might comprise a gene network that includes multiple cis-sense/antisense pairs.
In conclusion, we have provided the first evidence of bidirectional regulation between the WDR83 and DHPS genes in human cells. This pair of protein-coding cis-SA transcripts could play an important role in the tumorigenesis of GC, as it appears to be involved in the regulation of ERK signaling and E2F1 expression. Further studies of the cis-SA pair may provide a more complete understanding of their functions in tumor development and eventually open avenues for novel therapeutic interventions in cancer.
Materials and Methods
Clinical and histological evaluation of human samples in this study
The human samples in this study were approved by the local ethics committee at the Shanghai Jiao-Tong University School of Medicine Renji Hospital. This research was performed according to the provisions of the Helsinki Declaration of 1975. None of the patients received preoperative treatment, including radiotherapy or chemotherapy. All tumor samples were examined histologically and all nontumorous tissues were taken at a distance of at least 5 cm from the tumor, which were confirmed to be normal and free of tumor cells using hematoxylin-eosin staining.
qPCR analysis
Total RNA was extracted from 19 human GC specimens (cancer and adjacent nontumorous tissues). Primary GC tissues and their matched normal tissues were obtained with informed consent from 19 patients in the Department of Surgery, Shanghai JiaoTong University School of Medicine Renji Hospital, the methods for estimating the sample number was described in Supplementary information, Data S1.
RNA samples were treated with RNase-free DNase (Ambion, Austin, TX, USA) according to the manufacturer's instructions. Reverse transcription was performed with random primers using the First Strand cDNA Synthesis Kit (Takara, Shiga, Japan). qPCR was performed using an ABI Prism 7300HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA) with SYBR Premix Ex Taq II (Takara) and the 2 −∆∆CT method as described previously [44] . The expression of each target gene was normalized to that of GAPDH. The primer sequences used are listed in Supplementary information, Table S1 .
Subcellular transcriptional analysis of WDR83 and DHPS
The subcellular transcription of WDR83 and DHPS was analyzed using Affymetrix ENCODE Tiling Array, a tiling 91-array set containing probes against the non-repetitive portions of the human genome (details are described in Supplementary information, Data S1).
Immunohistochemistry
Immunohistochemistry (IHC) was performed using a standard streptavidin-biotin-peroxidase complex method [45] . In brief, slides with paraffin sections were deparaffinized and rehydrated. Endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide for 15 min. For antigen retrieval, slides were microwave treated and boiled in 10 mM citrate buffer (pH 6.0) for 10 min. Nonspecific binding was blocked with 10% normal rabbit serum for 30 min. The slides were incubated with anti-WDR83 (1:500, Abcam, Cambridge, UK) or anti-DHPS (1:500, Sigma-Aldrich, St Louis, MO, USA) antibody overnight at 4 °C. A negative control was obtained by replacing the primary antibody with PBS.
Cells and culture conditions
The human GC cell line MGC803 was cultured in RPMI-1640 medium (Gibco, Gaithersburg, MD, USA) supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin and maintained at 37 °C in a humidified atmosphere with 5% CO 2 . For the stimulation experiments, PMA (Sigma) was dissolved in DMSO and diluted with tissue culture media to a final concentration of 5 nM. α-Amanitin (Sigma) was dissolved in distilled water and diluted to a final concentration of 25 mM.
RNA interference
Commercial siRNAs that specifically targeted the coding regions in either WDR83 (GenBank accession number: NM_001099737) or DHPS (GenBank accession number: NM_001930) were purchased from Qiagen (Hilden, Germany). ERK1/2 siRNAs were used as described previously [46] . The uniqueness of the siRNA target sequences for the human genome was confirmed by the UCSC BLAT program. The siRNA sequences are listed in Supplementary information, Table S1 . Briefly, MGC803 cells were plated in regular growth medium at 40%-50% confluence in six-well tissue plates 24 h before transfection, and then transfected with 5 nM siRNA using HiPerFect Transfection Reagent (Qiagen) in accordance with the manufacturer's instructions. Nonspecific siRNAs (Qiagen) was used as the negative control. After 48 h, the cells were collected for various assays. The selective silencing was confirmed by qPCR and western blotting analysis.
2′-O-methyl oligoribonucleotides inhibition
Cells were plated in regular growth medium at 40%-50% confluence in 12-well tissue plates 24 h before transfection and then transfected with 2′-O-methyl oligoribonucleotides (Invitrogen) at a 40 pmol/ml concentration using Lipofectamine 2000 (Invitrogen). After 24 h, the cells were collected for qPCR analysis. The 2′-Omethyl oligoribonucleotide sequences are listed in Supplementary information, Table S1 .
Stability and α-amanitin treatment
MGC803 cells were plated in regular growth medium at 50%-60% confluence in six-well tissue plates 24 h before transfection and then transfected with 5 nM siRNA using HiPerFect Transfection Reagent (Qiagen) in accordance with the manufacturer's instructions. Nonspecific siRNA (Qiagen) was used as the negative control. After further 24 h incubation, cells were treated with 25 mM of α-amanitin and harvested for RNA purification and RT-PCR at 6, 12 and 24 h post treatment. We used three independent samples for each data point; all samples had untreated and untransfected matching samples for RNA purification and data analysis, as previously described [9] .
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Plasmids construction and transfection
Of the three splice variants of WDR83 transcripts, NM_001099737 and NM_032332 have coding potentials at the same coding regions. Full-length WDR83 cDNA (GenBank accession number: NM_001099737) was synthesized, and the CDS and 3′UTR were amplified by PCR from full-length WDR83 (the primers are listed in Supplementary information, Table S1 ). The pIRES2-EGFP vector (Clontech, Santa Clara, CA, USA) was used to construct three plasmids: pIRES2-WDR83-full length (the plasmid containing full-length WDR83), pIRES2-WDR83-CDS (the plasmid containing only the CDS region of WDR83) and pIRES2-WDR83-3′UTR (the plasmid containing only the 3′UTR of WDR83).
Of the three DHPS transcript variants, only NM_001930 encodes a protein with high DHPS activity [47, 48] . Full-length DHPS cDNA (GenBank accession number: NM_001930) was synthesized, and the CDS and 3′UTR were amplified by PCR from full-length DHPS (the primers are listed in Supplementary information, Table S1 ). Three plasmids were constructed: pIRES2-DHPS-full length (the plasmid containing full-length DHPS), pIRES2-DHPS-CDS (the plasmid containing the CDS region of DHPS) and pIRES2-DHPS-3′UTR (the plasmid containing the 3′UTR of DHPS).
All constructs were verified by DNA sequencing. For plasmid transfection, cells were seeded in six-well tissue culture dishes 24 h before transfection and then transfected with plasmids (3-4 µg) using Lipofectamine TM 2000 Reagent (Invitrogen) following the manufacturer's instructions. After 48 h of standard incubation, cells were trypsinized and used for various assays.
Luciferase assays
To further investigate whether the regulation between WDR83 and DHPS was mediated directly through their overlapping 3′UTRs, we constructed two luciferase reporter vectors: pmirGLO-WDR83-3′UTR and pmirGLO-DHPS-3′UTR (Supplementary information, Figure S5 ). The 3′UTR of WDR83 was amplified by PCR from the pIRES2-WDR83-3′UTR plasmid and inserted into the pmirGLO vector between the XhoI and SalI sites (Promega, Madison, WI, USA). The 3′UTR of DHPS was amplified by PCR from the pIRES2-DHPS-3′UTR plasmid and inserted into the pmirGLO vector between the SacI and XhoI sites. All constructs were verified by DNA sequencing. The plasmids were transfected into MGC803 cells with Lipofectamine 2000 (Invitrogen) as described previously. After 48 h of standard incubation, cells were assayed by the Dual-Luciferase Reporter Assay System Kit (Promega). All experiments were performed in triplicate with data pooled from at least three independent experiments.
RNase protection assay
The total RNA was purified by TRIzol reagent (Invitrogen). The RNA was divided into three parts: the sample of interest and the positive and negative controls. All samples were treated with DNase I (Invitrogen) in DNase I buffer. The negative control was heat-denatured at 94 °C for 15 min. Then, the sample of interest and negative control were treated with RNase A (Invitrogen) and the positive control was treated with RNase Out (Invitrogen) as previously described [9, 18] . Following the RPA assay, we used RT-PCR to detect duplex formation by primers within the overlapping region or non-overlapping regions (the primers are listed in Supplementary information, Table S1 ).
Western blotting
Western blotting was performed according to standard protocols as described previously [49] . Antibody information is listed in Supplementary information, Data S1.
Cell viability assay
Cell viability was assessed by a tetrazolium salt (WST-8)-based colorimetric assay using the Cell Counting Kit 8 (CCK-8; Dojindo, Rockville, MD, USA). Briefly, control and treated GC cells were seeded into 96-well plates at an initial density of 5 × 10 3 cells/well. At the specified time points, 10 µl of CCK-8 solution was added to each well and incubated for 1 h. Cell viability was determined by scanning with a microplate reader at 450 nm. Data were calculated as the percentage of viable cells as follows: relative viability (%) = (A450 (treated) − A450 (blank))/(A450 (control) − A450 (blank)) × 100%.
WDR83, DHPS, and E2F1 expression analysis in other cancers
The expression of WDR83, DHPS, and E2F1 in other cancers was analyzed using the Affymetrix Human Exon 1.0 ST array platform. The detailed protocol is shown in Supplementary information, Data S1.
Statistical analysis
Data are expressed as mean ± SD. Statistical differences between the two groups were determined by the Student's t-test.
Differences between multiple groups were tested using analysis of variance (ANOVA). Regression and correlation coefficient analyses were performed using GraphPad Prism (GraphPad Software, Inc., La Jolla, CA, USA). All experiments were repeated at least three times.
